Dhampur Bio Organics Ltd (DBOL) AI Stock Analysis

0 Followers

Dhampur Bio Organics Ltd

(NSE:DBOL)

Select Model

Rating:62Neutral

Price Target:INR 133.00▼(-8.90% Downside)

Action:reiterated

Date:10/07/26

Overall score is held back primarily by uneven financial performance: materially compressed margins, inconsistent cash generation (despite improvement in 2026), and moderate-to-elevated leverage with weaker ROE. Offsetting this, technicals are supportive with the stock trading above major moving averages and positive momentum, while valuation appears favorable with a low P/E and a modest dividend yield.

Positive Factors

Revenue GrowthThe reported 10.24% revenue growth indicates renewed top-line expansion, which can support better utilization of the company’s processing base and provide a broader revenue foundation. If sustained, growth would improve operating leverage and help rebuild earnings capacity over the next several quarters.

Negative Factors

Margin CompressionThe sharp reduction in net and gross margins leaves less profit from each unit of revenue and reduces the company’s ability to absorb operating or commodity-cost pressure. Persistently thin margins could constrain reinvestment, weaken earnings resilience and limit returns even if revenue grows.

Dhampur Bio Organics Ltd (DBOL) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 9.60B
Dividend Yield: 1.02%
Average Volume (3M): 21.55K
Price to Earnings (P/E): 11.5
Beta (1Y): 0.88
Revenue Growth: 10.24%
EPS Growth: ―
Country: India
Employees: 1,692
Sector: General
Sector Strength: 55
Industry: Agricultural Farm Products

Dhampur Bio Organics Ltd Business Overview & Revenue Model

Company Description

Dhampur Bio Organics Ltd., founded in 2020 and headquartered in New Delhi, India, functions as a holistic sugarcane processing enterprise. The company's operations in India involve the manufacturing and distribution of various products, such as refin...

How the Company Makes Money

DBOL makes money primarily by selling products derived from sugarcane processing through multiple revenue streams: (1) Sugar sales: The core revenue stream comes from manufacturing sugar and selling it to institutional buyers (such as wholesalers, in...

Dhampur Bio Organics Ltd Financial Statement Overview

Summary

Mixed fundamentals. Revenue recovered in 2026 but has been uneven versus prior years, profitability has compressed sharply (net margin ~1.2% in 2026 vs ~4.6% in 2023), and cash flow remains the key weakness due to inconsistency despite positive operating and free cash flow in 2026. Balance sheet leverage is moderate-to-elevated (debt-to-equity ~1.03) with weakened ROE (~2.5%).

Income Statement

55Neutral

Balance Sheet

58Neutral

Cash Flow

46Neutral

Financial statement breakdown
Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	21.17B	21.09B	18.62B	18.39B	24.08B	15.54B
Gross Profit	4.40B	3.39B	4.76B	3.65B	5.50B	2.20B
EBITDA	1.70B	1.63B	1.38B	1.59B	2.13B	1.90B
Net Income	839.70M	251.80M	146.90M	464.90M	1.11B	1.02B
Balance Sheet
Total Assets	0	23.22B	23.98B	23.13B	20.77B	20.01B
Cash, Cash Equivalents and Short-Term Investments	87.10M	361.60M	389.80M	293.90M	1.04B	229.80M
Total Debt	0	10.60B	11.62B	10.57B	8.10B	8.35B
Total Liabilities	-10.27B	12.95B	13.86B	13.01B	10.89B	11.23B
Stockholders Equity	10.27B	10.27B	10.12B	10.11B	9.89B	8.77B
Cash Flow
Free Cash Flow	6.69B	1.15B	-161.70M	-2.72B	1.45B	-4.08B
Operating Cash Flow	6.89B	1.59B	1.30B	-1.01B	3.55B	-2.46B
Investing Cash Flow	-178.20M	-422.00M	-1.46B	-1.66B	-1.96B	-1.38B
Financing Cash Flow	-6.52B	-1.17B	187.90M	1.70B	-781.20M	3.94B

Dhampur Bio Organics Ltd Technical Analysis

Technical Analysis SentimentPositive

Last Price146.00

Price Trends

50DMA128.22Positive

100DMA120.71Positive

200DMA113.24Positive

Market Momentum

MACD3.05Negative

RSI62.66Neutral

STOCH93.11Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DBOL, the sentiment is Positive. The current price of 146.00 is above the 20-day moving average (MA) of 131.45, above the 50-day MA of 128.22, and above the 200-day MA of 113.24, indicating a bullish trend. The MACD of 3.05 indicates Negative momentum. The RSI at 62.66 is Neutral, neither overbought nor oversold. The STOCH value of 93.11 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:DBOL.

Dhampur Bio Organics Ltd Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:DBOL against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:GODREJAGRO	72Outperform	INR 113.31B	24.27	―	1.86%	11.64%	7.78%
IN:KMSUGAR	71Outperform	INR 2.87B	4.76	―	―	-6.12%	29.03%
IN:DBOL	62Neutral	INR 9.56B	11.48	―	1.02%	10.24%	―
IN:SAKHTISUG	61Neutral	INR 2.33B	8.23	―	―	25.36%	203.89%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:KOTARISUG	45Neutral	INR 1.94B	14.22	―	―	12.18%	―
IN:RENUKA	40Underperform	INR 39.57B	-6.52	―	―	-9.87%	18.65%

* General Sector Average

Performance Comparison

IN:DBOL and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:DBOL	Dhampur Bio Organics Ltd	146.00	77.01	111.62%
IN:GODREJAGRO	Godrej Agrovet Limited	592.55	19.34	3.37%
IN:KMSUGAR	K.M. Sugar Mills Ltd.	31.64	9.23	41.20%
IN:KOTARISUG	Kothari Sugars & Chemicals Ltd.	23.46	-6.18	-20.85%
IN:RENUKA	Shree Renuka Sugars Limited	18.50	-9.62	-34.21%
IN:SAKHTISUG	Sakthi Sugars Limited	19.07	-0.88	-4.41%

Dhampur Bio Organics Ltd Corporate Events

Dhampur Bio Organics Announces Resignation of VP Financial Planning and Analysis

Oct 31, 2026

Dhampur Bio Organics Ltd. has announced the resignation of Harmeet Singh from his role as Vice President – Financial Planning and Analysis, following a letter submitted on October 9, 2026. His cessation from the position will be effective at the clos...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 06, 2026

Dhampur Bio Organics Ltd AI Stock Analysis